Author Title [ Type(Desc)] Year
Filters: Author is Duan, Wei  [Clear All Filters]
Journal Article
Zhou G, Bae SDa Won, Nguyen R, Huo X, Han S, Zhang Z, Hebbard L, Duan W, Eslam M, Liddle C, et al. An aptamer-based drug delivery agent (CD133-apt-Dox) selectively and effectively kills liver cancer stem-like cells. Cancer Lett. 2020.
Wang Y-Y, Yang Y-X, Zhao R, Pan S-T, Zhe H, He Z-X, Duan W, Zhang X, Yang T, Qiu J-X, et al. Bardoxolone methyl induces apoptosis and autophagy and inhibits epithelial-to-mesenchymal transition and stemness in esophageal squamous cancer cells. Drug Des Devel Ther. 2015;9:993-1026.
Moitra P, Misra SK, Kumar K, Kondaiah P, Tran P, Duan W, Bhattacharya S. Cancer Stem Cell-Targeted Gene Delivery Mediated by Aptamer-Decorated pH-Sensitive Nanoliposomes. ACS Biomater Sci Eng. 2021.
Wang T, Gantier MP, Xiang D, Bean AG, Bruce M, Zhou S-F, Khasraw M, Ward A, Wang L, Wei MQ, et al. EpCAM Aptamer-mediated Survivin Silencing Sensitized Cancer Stem Cells to Doxorubicin in a Breast Cancer Model. Theranostics. 2015;5(12):1456-72.
Lin J, Shigdar S, Fang DZhi, Xiang D, Wei MQ, Danks A, Kong L, Li L, Qiao L, Duan W. Improved Efficacy and Reduced Toxicity of Doxorubicin Encapsulated in Sulfatide-Containing Nanoliposome in a Glioma Model. PLoS One. 2014;9(7):e103736.
Xiang D, Shigdar S, Qiao G, Wang T, Kouzani AZ, Zhou S-F, Kong L, Li Y, Pu C, Duan W. Nucleic Acid Aptamer-Guided Cancer Therapeutics and Diagnostics: the Next Generation of Cancer Medicine. Theranostics. 2015;5(1):23-42.
Li J-P, Yang Y-X, Liu Q-L, Zhou Z-W, Pan S-T, He Z-X, Zhang X, Yang T, Pan S-Y, Duan W, et al. The pan-inhibitor of Aurora kinases danusertib induces apoptosis and autophagy and suppresses epithelial-to-mesenchymal transition in human breast cancer cells. Drug Des Devel Ther. 2015;9:1027-62.
Deng J, Wang L, Chen H, Hao J, Ni J, Chang L, Duan W, Graham P, Li Y. Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer. Oncotarget. 2016.
Chen X-W, He Z-X, Zhou Z-W, Yang T, Zhang X, Yang Y-X, Duan W, Zhou S-F. An update on the clinical pharmacology of the dipeptidyl peptidase 4 inhibitor alogliptin used for the treatment of type 2 diabetes mellitus. Clin Exp Pharmacol Physiol. 2015.